6 days Ago By ABMN Staff
Russell Investments Group Ltd. cut its position in DaVita Inc. ( NYSE:DVA – Free Report ) by 3.
9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 32,512 shares of the company’s stock after selling 1,321 shares during the period. Russell Investments Group Ltd.
’s holdings in DaVita were worth $4,864,000 at the end of the most recent reporting period. A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Aviva PLC increased its holdings in shares of DaVita by 427.
7% during the fourth quarter. Aviva PLC now owns 27,921 shares of the company’s stock valued at $4,176,000 after acquiring an additional 22,630 shares in the last quarter. Resona Asset Management Co.
Ltd. acquired a new position in DaVita during the fourth quarter worth $2,149,000. World Investment Advisors bought a new position in shares of DaVita in the fourth quarter valued at $222,000.
Huntington National Bank grew its holdings in shares of DaVita by 17.6% during the fourth quarter. Huntington National Bank now owns 903 shares of the company’s stock valued at $135,000 after buying an additional 135 shares during the last quarter.
Finally, Kesler Norman & Wride LLC increased its position in shares of DaVita by 40.2% during the fourth quarter. Kesler Norman & Wride LLC now owns 4,874 shares of the company’s stock worth $729,000 after acquiring an additional 1,397 shares in the last quarter.
90.12% of the stock is owned by institutional investors. DaVita Stock Down 3.
0 % DVA stock opened at $150.85 on Tuesday. DaVita Inc.
has a 1-year low of $125.64 and a 1-year high of $179.60.
The stock has a market cap of $12.07 billion, a P/E ratio of 14.05, a P/E/G ratio of 1.
07 and a beta of 1.04. The stock’s fifty day simple moving average is $151.
61 and its two-hundred day simple moving average is $156.51. The company has a current ratio of 1.
26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18.
Analysts Set New Price Targets A number of equities analysts have issued reports on the company. Cowen reiterated a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. StockNews.
com raised DaVita from a “hold” rating to a “buy” rating in a research report on Thursday, April 10th. Barclays increased their price target on DaVita from $164.00 to $169.
00 and gave the company an “equal weight” rating in a research report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.
00 target price on shares of DaVita in a research note on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat.
com, the company currently has an average rating of “Hold” and an average target price of $166.33. Get Our Latest Research Report on DaVita DaVita Profile ( Free Report ) DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.
The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. Featured Stories Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for DaVita Inc. ( NYSE:DVA – Free Report ). Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.
com's FREE daily email newsletter ..
